Search research articles
Contact Us
Filters
Showing results (481-490 of 662) with videos related to
Page
of 67
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 6, 2010
Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience
Alexandra Boehm, Barbara Walcherberger, Wolfgang R Sperr, et al.
The Journal of Allergy and Clinical Immunology
|
July 9, 2025
Evolution of mast cell research associated with the Laboratory of Allergic Diseases, 1985-2022: Summary of the 2023 NIAID Symposium
Hirsh D Komarow, Gunnar Nilsson, Yoshimichi Okayama, et al.
Blood
|
March 17, 2024
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
Francesco Onida, Nico Gagelmann, Yves Chalandon, et al.
International Journal of Clinical and Health Psychology : IJCHP
|
September 4, 2023
The impact of COVID-19 and socioeconomic status on psychological distress in cancer patients
Elisabeth Lucia Zeilinger, Matthias Knefel, Carmen Schneckenreiter, et al.
Blood
|
July 28, 2021
A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells
Sebastian Kollmann, Reinhard Grausenburger, Thorsten Klampfl, et al.
Haematologica
|
June 10, 2017
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
Karoline V Gleixner, Mathias Schneeweiss, Gregor Eisenwort, et al.
Expert Review of Hematology
|
July 26, 2023
Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives
Peter Valent, Irina Sadovnik, Barbara Peter, et al.
Ebiomedicine
|
November 26, 2019
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1<sup>T315I</sup>+ clones in TKI-resistant CML
Mathias Schneeweiss-Gleixner, Konstantin Byrgazov, Gabriele Stefanzl, et al.
Wiener Klinische Wochenschrift
|
October 12, 2010
First annual report of the Austrian CML registry
Stefan Schmidt, Dominik Wolf, Josef Thaler, et al.
Cancer Management and Research
|
June 1, 2011
Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics
Volker Wacheck, Michael Lahn, Gemma Dickinson, et al.
Page
of 67
Search research articles
Search
Showing results (481-490 of 662) with videos related to
Sort By:
Page
of 67
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 6, 2010
Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience
Alexandra Boehm, Barbara Walcherberger, Wolfgang R Sperr, et al.
The Journal of Allergy and Clinical Immunology
|
July 9, 2025
Evolution of mast cell research associated with the Laboratory of Allergic Diseases, 1985-2022: Summary of the 2023 NIAID Symposium
Hirsh D Komarow, Gunnar Nilsson, Yoshimichi Okayama, et al.
Blood
|
March 17, 2024
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
Francesco Onida, Nico Gagelmann, Yves Chalandon, et al.
International Journal of Clinical and Health Psychology : IJCHP
|
September 4, 2023
The impact of COVID-19 and socioeconomic status on psychological distress in cancer patients
Elisabeth Lucia Zeilinger, Matthias Knefel, Carmen Schneckenreiter, et al.
Blood
|
July 28, 2021
A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells
Sebastian Kollmann, Reinhard Grausenburger, Thorsten Klampfl, et al.
Haematologica
|
June 10, 2017
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
Karoline V Gleixner, Mathias Schneeweiss, Gregor Eisenwort, et al.
Expert Review of Hematology
|
July 26, 2023
Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives
Peter Valent, Irina Sadovnik, Barbara Peter, et al.
Ebiomedicine
|
November 26, 2019
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1<sup>T315I</sup>+ clones in TKI-resistant CML
Mathias Schneeweiss-Gleixner, Konstantin Byrgazov, Gabriele Stefanzl, et al.
Wiener Klinische Wochenschrift
|
October 12, 2010
First annual report of the Austrian CML registry
Stefan Schmidt, Dominik Wolf, Josef Thaler, et al.
Cancer Management and Research
|
June 1, 2011
Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics
Volker Wacheck, Michael Lahn, Gemma Dickinson, et al.
Page
of 67